AVANOS MEDICAL, INC. Quarterly Income Tax Expense (Benefit) in USD from Q3 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Avanos Medical, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2013 to Q2 2024.
  • Avanos Medical, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $1.9M.
  • Avanos Medical, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $7M.
  • Avanos Medical, Inc. annual Income Tax Expense (Benefit) for 2023 was $2M, a 61.5% decline from 2022.
  • Avanos Medical, Inc. annual Income Tax Expense (Benefit) for 2022 was $5.2M.
  • Avanos Medical, Inc. annual Income Tax Expense (Benefit) for 2021 was -$11.2M, a 67% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7M $1.9M +$2.7M Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $4.3M $1M +$2.3M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $2M -$2.1M -$3.5M -250% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $5.5M $6.2M +$7.1M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 -$1.6M -$800K -$3.6M -129% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $2M -$1.3M -$3.2M -168% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $5.2M $1.4M -$1.2M -46.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $6.4M -$900K -$38.9M -102% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $45.3M $2.8M +$48.8M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$3.5M $1.9M +$7.7M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 -$11.2M $2.6M +$3.4M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 -$14.6M $38M +$61.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$76.1M -$46M -$43.1M -1486% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-02
Q1 2021 -$33M -$5.8M +$900K +13.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-02
Q4 2020 -$33.9M -$800K -$400K -100% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 -$33.5M -$23.5M -$14.7M -167% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$18.8M -$2.9M +$400K +12.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$19.2M -$6.7M -$1.1M -19.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$18.1M -$400K +$6.3M +94% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 -$24.4M -$8.8M -$9.6M -1200% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 -$14.8M -$3.3M -$3.1M -1550% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 -$11.7M -$5.6M -$2.1M -60% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$9.6M -$6.7M +$7.9M +54.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 -$17.5M $800K +$8.4M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$25.9M -$200K +$7.8M +97.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$33.7M -$3.5M +$6.4M +64.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$40.1M -$14.6M +$58.9M +80.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 -$99M -$7.6M -$11.2M -311% Jul 1, 2017 Sep 30, 2017 10-Q/A 2018-12-17
Q2 2017 -$87.8M -$8M -$10.9M -376% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$76.9M -$9.9M -$21M -189% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 -$55.9M -$73.5M +$11.6M +13.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 -$67.5M $3.6M +$2.1M +140% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 -$69.6M $2.9M -$2.4M -45.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 -$67.2M $11.1M +$100K +0.91% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 -$67.3M -$85.1M -$106M -515% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $38.3M $1.5M -$19.9M -93% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $58.2M $5.3M +$4.4M +489% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $53.8M $11M -$10.3M -48.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $64.1M $20.5M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $21.4M -$1.7M -7.36% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $900K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $21.3M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q3 2013 $23.1M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.